p130Cas Is Correlated with EREG Expression and a Prognostic Factor Depending on Colorectal Cancer Stage and Localization Reducing FOLFIRI Efficacy
p130 Crk-associated substrate (p130Cas) is associated with poor prognosis and treatment resistance in breast and lung cancers. To elucidate p130Cas functional and clinical role in colorectal cancer (CRC) progression/therapy resistance, we performed cell culture experiments and bioinformatic/statisti...
Guardado en:
Autores principales: | Jörg Kumbrink, Pan Li, Agnes Pók-Udvari, Frederick Klauschen, Thomas Kirchner, Andreas Jung |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/695e70acc2594d1bafe0acdcd21486e1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MiR-130a-3p suppresses colorectal cancer growth by targeting Wnt Family Member 1 (WNT1)
por: Guang-Lin Song, et al.
Publicado: (2021) -
CRISPR/Cas9 in Gastrointestinal Malignancies
por: André Jefremow, et al.
Publicado: (2021) -
Bioinformational analysis of Yersinia pseudotuberculosis IP32953 CRISPR/cas system
por: N. P. Peretolchina, et al.
Publicado: (2016) -
Revealing the composition of the eukaryotic microbiome of oyster spat by CRISPR-Cas Selective Amplicon Sequencing (CCSAS)
por: Kevin Xu Zhong, et al.
Publicado: (2021) -
Characterization of a Type II-A CRISPR-Cas System in <italic toggle="yes">Streptococcus mutans</italic>
por: Cas Mosterd, et al.
Publicado: (2020)